Lodestone Biomedical
Lodestone Biomedical, with a valuation of $12.49 million, is raising funds on StartEngine. The company makes implantable biosensors that allow cancer researchers to monitor real-time changes in tumors. Lodestone Biomedical’s technology enables researchers to make faster and more data-driven decisions and accelerates drug discovery. The company has a strong potential and has generated $2.61 million in revenue from NIH and CRI-funded projects with Dartmouth and Yale. Solomon Diamond founded Lodestone Biomedical in June 2015. The current crowdfunding campaign has a minimum target of $123,998.91 and a maximum target of $1.23 million. The campaign proceeds will be used for research and development, inventory, company employment, and working capital.
Investment Overview
Raised: $55,263
Deal Terms
Total Commitments ($USD)
- Platform
- StartEngine
- Start Date
- 11/18/2024
- Close Date
- 02/18/2025
$123,999
$1,235,000
$101
Equity - Common
Seed
RegCF
$1.47
$12,495,000
Company & Team
Company
- Year Founded
- 2015
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2B
- Margin
- Medium
- Capital Intensity
- High
Financials
- Revenue +103% YoY
- $957,211
- Monthly Burn
- $60,000
-
Runway
- 7.2 months
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Company Funding & Growth
Funding history
- Total Prior Capital Raised
- $550,000
- VC Backed?
- No
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 02/18/2025 | StartEngine | $12,495,000 | $55,263 | Equity - Common | Active | RegCF |